ImmunoPrecise Antibodies Ltd. ( NASDAQ: IPA) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - Interim Chief ...

The field is evolving—don’t get left behind. Expand your network and join 80+ structural biologists, medicinal chemists, ...

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

Writing in Cell Reports, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators have presented a multifaceted analysis and structure-function study of a ...

Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is caused by the body's own antibodies, which inhibit important defense ...

Early animal studies show that a single vaccine could protect the recipient from different variants of the coronaviruses that ...

ProMIS Neurosciences (PMN) announced plans to deliver virtual oral presentations at the 2025 Alzheimer’s and Parkison’s Disease International ...

Scientists from UNIGE have developed synthetic molecules that mimic antibodies. They could revolutionize the treatment of ...

Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.

The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.